United States · Series E startup
6 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by bizjournals.comSEC filing: $8.5M sold, first sale May 2013
Reported by businesswire.com
No investor was named in the report.
Reported by fis.dowjones.comSEC filing: $14M sold, first sale Feb 2011
No investor was named in the report.
Reported by xconomy.comSEC filing: $21M sold, first sale Jun 2009
No investor was named in the report.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Polaris Partners
Versant VenturesSV Life Sciences
Ascension VenturesBaxter VenturesMissing a round, or an investor who was in one? Tell us.
Ocular Therapeutix's investors include Polaris Partners, Versant Ventures, SV Life Sciences, Ascension Ventures and Baxter Ventures.
Ocular Therapeutix has raised $73M across 6 rounds since 2009.
Ocular Therapeutix's most recent round was a Series E of $8.5M in Jun 2013.
Ocular Therapeutix's largest round on record is $24M (Series D), in Jan 2013.
Ocular Therapeutix's first round on record, in Jun 2009, was backed by Polaris Partners, Versant Ventures and SV Life Sciences.
Ocular Therapeutix's latest named round is a Series E, in Jun 2013.
Ocular Therapeutix is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·